> top > docs > PMC:7264098 > spans > 514-731 > annotations

PMC:7264098 / 514-731 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T11 0-9 CL:0000034 denotes Stem cell
T12 46-54 GO:0046903 denotes secreted
T13 55-77 GO:1903561 denotes extracellular vesicles
T14 186-190 UBERON:0002048 denotes lung
T15 208-216 SP_7 denotes COVID-19
T58760 0-9 CL:0000034 denotes Stem cell
T64561 46-54 GO:0046903 denotes secreted
T18890 55-77 GO:1903561 denotes extracellular vesicles
T99029 186-190 UBERON:0002048 denotes lung
T42833 208-216 SP_7 denotes COVID-19

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
24 149-161 Disease denotes inflammation MESH:D007249
25 186-197 Disease denotes lung damage MESH:D008171
26 208-216 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T7 0-9 Body_part denotes Stem cell http://purl.org/sig/ont/fma/fma63368
T8 5-9 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T9 186-190 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T3 186-190 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T5 149-161 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T6 208-216 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T8 0-9 http://purl.obolibrary.org/obo/CL_0000034 denotes Stem cell
T9 186-190 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T10 186-190 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 149-161 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T6 0-217 Sentence denotes Stem cell therapies and, more recently, their secreted extracellular vesicles (EVs), are emerging as new promising treatments, which could attenuate inflammation but also regenerate the lung damage caused by COVID-19.